Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

NCT03980769 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder

Interventions

DRUG: Thiotepa
DRUG: Treosulfan
DRUG: Fludarabine Phosphate
BIOLOGICAL: Rabbit Anti-Thymocyte Globulin
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Biospecimen Collection

Sponsor

Fred Hutchinson Cancer Center